קונבריזה

Land: Israel

Språk: hebreiska

Källa: Ministry of Health

Aktiva substanser:

BAZEDOXIFENE AS ACETATE 20 MG

Tillgänglig från:

NEOPHARM LTD

ATC-kod:

G03XC02

Läkemedelsform:

COATED TABLETS

Administreringssätt:

PER OS

Tillverkad av:

PFIZER IRELAND PHARMACEUTICALS

Terapeutisk grupp:

BAZEDOXIFENE

Terapeutiska indikationer:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

Tillstånd datum:

2013-04-01